“Thyroid nodular disease and PTEN mutation in a multicentre series of children with PTEN hamartoma tumor syndrome (PHTS)”
-
Published:2021-06-28
Issue:3
Volume:74
Page:632-637
-
ISSN:1355-008X
-
Container-title:Endocrine
-
language:en
-
Short-container-title:Endocrine
Author:
Tuli GerdiORCID, Munarin Jessica, Mussa Alessandro, Carli Diana, Gastaldi Roberto, Borgia Paola, Vigone Maria Cristina, Abbate Marco, Ferrero Giovanni Battista, De Sanctis Luisa
Abstract
Abstract
Purpose
To report the incidence of 4–12% of differentiated thyroid cancer (DTC) and up to 50% of benign thyroid nodular disease and to describe nodular thyroid disease in a multicentre pediatric population with PTEN mutations. Methods: Retrospective data of pediatric patients with PTEN mutations collected from tertiary Departments of Pediatric Endocrinology of Turin, Milan and Genua, Italy, in the period 2010–2020.
Results
Seventeen children with PTEN mutations were recruited in the study. Thyroid involvement was present in 12/17 (70.6%) subjects, showing a multinodular struma in 6/17 (35.3%), nodules with benign ultrasound features in 5/17 (29.4%) and a follicular adenoma in 1/17 (6%). No correlation was found between thyroid disease and gender, puberty, vascular manifestations, delayed development, or brain MRI abnormalities, while multiple lipomas were associated with thyroid disease (p = 0.03), as was macrocephaly. Standard Deviation (SD) score head circumference was 4.35 ± 1.35 cm in subjects with thyroid disease, 3 ± 0.43 cm (p = 0.02) in the group without thyroid disease. Thyroid involvement was present in all subjects with mutations in exon 6 (4/4) and exon 8 (3/3) of the PTEN gene (p = 0.02).
Conclusion
In the presented cohort, benign thyroid disorders were prevalent, with no evidence of DTC. A correlation was found between thyroid lesions and head circumference and the occurrence of multiple lipomas. Future studies in larger cohorts should assess whether risk stratification is needed when recommending surveillance strategies in children or young adolescents with PTEN hamartoma syndrome.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference10 articles.
1. Ciaccio C., Saletti V., D’Arrigo S., Esposito S., Alfei E., Moroni I., Tonduti D., Chiapparini L., Pantaleoni C., Milani D. Clinical spectrum of PTEN mutation in pediatric patients. A bicenter experience. Eur. J. Med. Genet. (2019) https://doi.org/10.1016/j.ejmg.2018.12.001 2. G.M. Blumenthal, P.A. Dennis, PTEN hamartoma tumor syndromes. Eur. J. Hum. Genet. 16, 1289–1300 (2008) 3. R.J. Gorlin, M.M. Cohen Jr, L.M. Condon, B.A. Burke, Bannayan-Riley-Ruvalcaba syndrome. Am. J. Med. Genet. 44, 307–314 (1992) 4. D.J. Marsh, V. Coulon, K.L. Lunetta, P. Rocca-Serra, P.L. Dahia, Z. Zheng, D. Liaw, S. Caron, B. Duboué, A.Y. Lin, A.L. Richardson, J.M. Bonnetblanc, J.M. Bressieux, A. Cabarrot-Moreau, A. Chompret, L. Demange, R.A. Eeles, A.M. Yahanda, E.R. Fearon, J.P. Fricker, R.J. Gorlin, S.V. Hodgson, S. Huson, D. Lacombe, C. Eng et al. Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. Hum. Mol. Genet. 7, 507–515 (1998) 5. D.J. Marsh, V. Coulon, K.L. Lunetta, P. Rocca-Serra, P.L.M. Dahia, Z. Zheng, D. Liaw, S. Caron, B. Duboué, A.Y. Lin, A.-L. Richardson, J.-M. Bonnetblanc, J.-M. Bressieux, A. Cabarrot-Moreau, A. Chompret, L. Demange, R.A. Eeles, A.M. Yahanda, E.R. Fearon, J.-P. Fricker, R.J. Gorlin, S.V. Hodgson, S. Huson, D. Lacombe, F. LePrat, S. Odent, C. Toulouse, O.I. Olopade, H. Sobol, S. Tishler, C.G. Woods, B.G. Robinson, H.C. Weber, R. Parsons, M. Peacocke, M. Longy, C. Eng, Mutation spectrum and genotype-phenotype analyses in cowden disease and Bannayan-Zonana Syndrome, two Hamartoma syndromes with germline PTEN mutation. Hum. Mol. Genet. 7, 507–515 (1998)
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|